PharmaJet Announces Appointment of Kevin L. Lorenz, J.D., to Board of Directors

GOLDEN, Colo. — December 17, 2019 — PharmaJet®, the maker of innovative, needle-free injection technology, today announced that Kevin L. Lorenz, J.D., has been appointed to its Board of Directors. Mr. Lorenz, Chief Investment Officer, Senior Vice President, Treasury and Private Investments at the Katz Group, is an accomplished executive with over 25 years of experience guiding and implementing investment strategy across public and private companies.